BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9832161)

  • 1. Expression and activity of cyclin-dependent kinase 5/p35 in adult rat peripheral nervous system.
    Terada M; Yasuda H; Kogawa S; Maeda K; Haneda M; Hidaka H; Kashiwagi A; Kikkawa R
    J Neurochem; 1998 Dec; 71(6):2600-6. PubMed ID: 9832161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Rho-family GTPases (Rac, cdc42, RhoA) and their association with p-21 activated kinase in adult rat peripheral nerve.
    Terashima T; Yasuda H; Terada M; Kogawa S; Maeda K; Haneda M; Kashiwagi A; Kikkawa R
    J Neurochem; 2001 May; 77(4):986-93. PubMed ID: 11359863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation.
    Nikolic M; Dudek H; Kwon YT; Ramos YF; Tsai LH
    Genes Dev; 1996 Apr; 10(7):816-25. PubMed ID: 8846918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct cellular compartment of cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activator protein (p35nck5a) in the developing rat cerebellum.
    Matsushita M; Tomizawa K; Lu YF; Moriwaki A; Tokuda M; Itano T; Wang JH; Hatase O; Matsui H
    Brain Res; 1996 Sep; 734(1-2):319-22. PubMed ID: 8896840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent kinase 5 activity regulates pain signaling.
    Pareek TK; Keller J; Kesavapany S; Pant HC; Iadarola MJ; Brady RO; Kulkarni AB
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):791-6. PubMed ID: 16407116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons.
    Lee MH; Nikolic M; Baptista CA; Lai E; Tsai LH; Massagué J
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3259-63. PubMed ID: 8622924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p35/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity.
    Nikolic M; Chou MM; Lu W; Mayer BJ; Tsai LH
    Nature; 1998 Sep; 395(6698):194-8. PubMed ID: 9744280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system.
    Zheng M; Leung CL; Liem RK
    J Neurobiol; 1998 May; 35(2):141-59. PubMed ID: 9581970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5.
    Tsai LH; Delalle I; Caviness VS; Chae T; Harlow E
    Nature; 1994 Sep; 371(6496):419-23. PubMed ID: 8090221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pctaire1 interacts with p35 and is a novel substrate for Cdk5/p35.
    Cheng K; Li Z; Fu WY; Wang JH; Fu AK; Ip NY
    J Biol Chem; 2002 Aug; 277(35):31988-93. PubMed ID: 12084709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol inhibits Cdk5 activity through regulation of p35 expression.
    Utreras E; Terse A; Keller J; Iadarola MJ; Kulkarni AB
    Mol Pain; 2011 Jul; 7():49. PubMed ID: 21736731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic contributions of cyclin-dependant kinase 5/p35 and Reelin/Dab1 to the positioning of cortical neurons in the developing mouse brain.
    Ohshima T; Ogawa M; Veeranna ; Hirasawa M; Longenecker G; Ishiguro K; Pant HC; Brady RO; Kulkarni AB; Mikoshiba K
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2764-9. PubMed ID: 11226314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel, membrane-associated neuronal kinase, cyclin-dependent kinase 5/p35-regulated kinase.
    Kesavapany S; Lau KF; Ackerley S; Banner SJ; Shemilt SJ; Cooper JD; Leigh PN; Shaw CE; McLoughlin DM; Miller CC
    J Neurosci; 2003 Jun; 23(12):4975-83. PubMed ID: 12832520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of Cdk5 activity in rat skeletal muscle after nerve injury.
    Fu WY; Fu AK; Lok KC; Ip FC; Ip NY
    Neuroreport; 2002 Feb; 13(2):243-7. PubMed ID: 11893918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells.
    Ubeda M; Kemp DM; Habener JF
    Endocrinology; 2004 Jun; 145(6):3023-31. PubMed ID: 14976144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of cyclin-dependent kinase 5 and its activator p35 with apoptotic cell death.
    Ahuja HS; Zhu Y; Zakeri Z
    Dev Genet; 1997; 21(4):258-67. PubMed ID: 9438340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of cyclin-dependent kinase 5 in 2,5-hexanedione-induced neuropathy.
    Wang QS; Zhang CL; Hou LY; Zhao XL; Yang XW; Xie KQ
    Toxicology; 2008 Jun; 248(1):1-7. PubMed ID: 18423835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of substance P and calcitonin gene-related peptide in dorsal root ganglia and dorsal horn after neonatal sciatic nerve lesion.
    Nothias F; Tessler A; Murray M
    J Comp Neurol; 1993 Aug; 334(3):370-84. PubMed ID: 7690784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Cdk5, p35, and Cdk5-associated kinase activity in the developing rat lens.
    Gao CY; Zakeri Z; Zhu Y; He H; Zelenka PS
    Dev Genet; 1997; 20(3):267-75. PubMed ID: 9216066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator.
    Hisanaga S; Saito T
    Neurosignals; 2003; 12(4-5):221-9. PubMed ID: 14673209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.